Altered microRNA expression in severe COVID-19: Potential prognostic and pathophysiological role
Clin Transl Med
.
2022 Jun;12(6):e899.
doi: 10.1002/ctm2.899.
Authors
Nathalie Garnier
1
,
Kato Pollet
1
2
,
Marie Fourcot
3
,
Morgan Caplan
4
,
Guillemette Marot
5
,
Julien Goutay
4
,
Julien Labreuche
6
,
Fabrice Soncin
7
8
,
Rabah Boukherroub
2
,
Didier Hober
1
;
Lille COVID Research Network (LICORNE)
;
Sabine Szunerits
2
,
Julien Poissy
4
9
,
Ilka Engelmann
1
Affiliations
1
Univ Lille, CHU Lille, Laboratoire de Virologie ULR3610, Lille, France.
2
Univ Lille, CNRS, Centrale Lille, Univ. Polytechnique Hauts-de-France, UMR 8520 - IEMN, Lille, France.
3
Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, Lille, France.
4
CHU de Lille, Pôle de réanimation, Lille, France.
5
Univ Lille, CHU Lille, ULR 2694 - METRICS, Lille, France.
6
Department of Biostatistics, CHU Lille, Lille, France.
7
CNRS/IIS/Centre Oscar Lambret/Lille University SMMiL-E Project, CNRS Délégation Hauts-de-France, Lille, France.
8
Laboratory for Integrated Micro Mechatronic Systems, Institute of Industrial Science, University of Tokyo,CNRS IRL2820, Tokyo, Japan.
9
CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, Inserm U1285, Univ Lille, CHU Lille, Lille, France.
PMID:
35696619
PMCID:
PMC9191908
DOI:
10.1002/ctm2.899
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19* / genetics
Gene Expression Regulation, Neoplastic
Humans
MicroRNAs* / genetics
Prognosis
Substances
MicroRNAs